Published in Front Biosci (Elite Ed) on January 01, 2012
Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc Natl Acad Sci U S A (1975) 2.55
Hair dye use and risk of fatal cancers in U.S. women. J Natl Cancer Inst (1994) 2.46
Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst (1980) 2.44
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 2.36
Personal use of hair dyes and risk of cancer: a meta-analysis. JAMA (2005) 2.02
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis (2007) 1.94
Use of permanent hair dyes and cancer among registered nurses. Lancet (1979) 1.89
Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol (2004) 1.65
Identification of aminobiphenyl derivatives in commercial hair dyes. Chem Res Toxicol (2003) 1.58
Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health (1992) 1.48
Breast cancer among radiologic technologists. JAMA (1995) 1.43
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 1.43
Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev (1994) 1.38
An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst (1987) 1.28
Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med (1999) 1.23
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol (2008) 1.23
Association between personal use of hair dyes and lymphoid neoplasms in Europe. Am J Epidemiol (2006) 1.22
Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis (2003) 1.16
Risk factors for Wilms tumor. Report from the National Wilms Tumor Study. Cancer (1993) 1.14
Hair dyes and bladder cancer. Can Med Assoc J (1977) 1.14
Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2004) 1.07
Hutchinson's melanotic freckle melanoma associated with non-permanent hair dyes. Br J Cancer (1983) 1.04
A case-control study of hair dye use and breast cancer. J Natl Cancer Inst (1979) 1.03
Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control (1999) 1.03
A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States). Cancer Causes Control (2002) 1.03
A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst (1994) 1.03
Hair dye use and risk of leukemia and lymphoma. Am J Public Health (1988) 1.03
Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg (1990) 0.99
Personal use of hair dyes and risk of bladder cancer: a meta-analysis of epidemiologic data. Cancer Causes Control (2008) 0.99
Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol (1994) 0.97
The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer (1988) 0.96
Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer. Int J Cancer (1993) 0.95
Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma. Am J Epidemiol (2007) 0.95
Regular use of hair dyes and risk of lymphoma in Spain. Int J Epidemiol (2005) 0.94
Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer (2006) 0.93
Bladder cancer risk and personal hair dye use. Int J Cancer (2004) 0.92
Carcinogenicity of some aromatic amines, organic dyes, and related exposures. Lancet Oncol (2008) 0.92
Personal use of hair dye and cancer risk in a prospective cohort of Chinese women. Cancer Sci (2009) 0.92
Case-control study of hair dye use by patients with breast cancer and endometrial cancer. J Natl Cancer Inst (1979) 0.92
Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr (1985) 0.91
Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case-control study. Cancer Epidemiol Biomarkers Prev (2006) 0.90
Hair dye use and risk of adult acute leukemia. Am J Epidemiol (2004) 0.89
A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res (1996) 0.89
Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res (1999) 0.89
Relationship of hair dye use, benign breast disease, and breast cancer. J Natl Cancer Inst (1980) 0.89
Personal use of hair dyes and hematolymphopoietic malignancies. Arch Environ Occup Health (2007) 0.88
Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco bay area. Am J Public Health (1998) 0.88
A case-control study of hair-dye use and cancers of various sites. Br J Cancer (1981) 0.87
Use of hair dyes and risk of bladder cancer. Cancer Res (1982) 0.87
Hair dye use and risk of lymphoid neoplasms and soft tissue sarcomas. Int J Cancer (2005) 0.87
Personal use of hair dyes and the risk of bladder cancer: results of a meta-analysis. Public Health Rep (2005) 0.86
Smoking, alcohol, occupation, and hair dye use in cancer of the lower urinary tract. Am J Epidemiol (1989) 0.85
Maternal hair dye use and risk of neuroblastoma in offspring. Cancer Causes Control (2005) 0.85
Use of hair colouring products and breast cancer risk: a case-control study in Connecticut. Eur J Cancer (2002) 0.85
Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia? Occup Environ Med (2001) 0.85
Hair dye use and multiple myeloma in white men. Am J Public Health (1992) 0.84
Use of permanent hair dyes and risk of breast cancer. J Natl Cancer Inst (1987) 0.84
Risk factors for breast cancer in Jordanian women. J Nurs Scholarsh (2002) 0.83
Hair dyes and risk of glioma among Nebraska women. Cancer Causes Control (2005) 0.83
Hair product use and the risk of breast cancer in young women. Cancer Causes Control (1999) 0.83
Hair dye use and breast cancer: a case-control study among screening participants. Am J Epidemiol (1991) 0.83
Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. Am J Epidemiol (2006) 0.82
A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of personal characteristics, lifestyle, and environmental risk factors by subtypes of the WHO classification. J Occup Environ Med (2010) 0.82
Exposure to hair-coloring products and the risk of multiple myeloma. Am J Public Health (1994) 0.81
Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma. Am J Epidemiol (2009) 0.81
Use of hair dyes by patients with breast cancer: a case-control study. Br Med J (1977) 0.80
West Coast study of childhood brain tumours and maternal use of hair-colouring products. Paediatr Perinat Epidemiol (2002) 0.78
Brick mortar exposure and chronic lymphocytic leukemia. Neoplasma (1995) 0.78
Use of hair colouring products and risk of multiple myeloma among US women. Occup Environ Med (2008) 0.78
An epidemiologic case-control study of breast cancer and exposure to hair dyes. Ann Epidemiol (1992) 0.76
Epidemiology of breast cancer and hair dyes. J Natl Cancer Inst (1983) 0.76
Are hair dyes associated with bladder cancer? Can Med Assoc J (1978) 0.76
Empirical analysis of transcriptional activity in the Arabidopsis genome. Science (2003) 11.62
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control (2008) 3.72
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Understanding the anatomic basis for obstructive sleep apnea syndrome in adolescents. Am J Respir Crit Care Med (2015) 2.68
microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res (2009) 2.51
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood (2006) 2.06
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer (2008) 2.02
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis (2011) 1.81
Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg (2005) 1.66
Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol (2004) 1.65
A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid (2009) 1.62
Single slice vs. volumetric MR assessment of visceral adipose tissue: reliability and validity among the overweight and obese. Obesity (Silver Spring) (2012) 1.60
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control (2004) 1.59
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women. Leuk Lymphoma (2010) 1.55
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One (2009) 1.52
Enhanced angiogenesis with multimodal cell-based gene therapy. Ann Thorac Surg (2007) 1.48
Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev (2005) 1.47
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet (2006) 1.47
Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis (2004) 1.47
Variation in lung cancer risk by smoky coal subtype in Xuanwei, China. Int J Cancer (2008) 1.45
Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res (2009) 1.45
CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res (2010) 1.45
Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control (2008) 1.43
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol (2004) 1.42
Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst (2004) 1.39
Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr (2007) 1.33
Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer (2005) 1.32
Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis (2006) 1.32
Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis (2008) 1.32
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat (2007) 1.30
Do Polybrominated Diphenyl Ethers (PBDEs) Increase the Risk of Thyroid Cancer? Biosci Hypotheses (2008) 1.29
Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat (2010) 1.28
Coal use, stove improvement, and adult pneumonia mortality in Xuanwei, China: a retrospective cohort study. Environ Health Perspect (2008) 1.28
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res (2008) 1.27
Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control (2003) 1.26
Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet (2006) 1.24
Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev (2008) 1.23
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol (2008) 1.23
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res (2009) 1.22
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer (2007) 1.21
A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2005) 1.20
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev (2009) 1.17
A global assessment of chromium pollution using sperm whales (Physeter macrocephalus) as an indicator species. Chemosphere (2009) 1.16
Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev (2005) 1.15
Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol (2008) 1.14
Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res (2009) 1.13
Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prev (2006) 1.13
Time trends in oral clefts in Chinese newborns: data from the Chinese National Birth Defects Monitoring Network. Birth Defects Res A Clin Mol Teratol (2010) 1.10
Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis (2004) 1.09
Hexavalent chromium is cytotoxic and genotoxic to the North Atlantic right whale (Eubalaena glacialis) lung and testes fibroblasts. Mutat Res (2007) 1.08
Quantitative airway analysis during drug-induced sleep endoscopy for evaluation of sleep apnea. Laryngoscope (2012) 1.07
A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev (2005) 1.07
Maximizing ventricular function with multimodal cell-based gene therapy. Circulation (2005) 1.06
Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2004) 1.06
Household air pollution and lung cancer in China: a review of studies in Xuanwei. Chin J Cancer (2014) 1.05
Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res (2005) 1.04
Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. Am J Epidemiol (2004) 1.04
Identification of gene-environment interactions in cancer studies using penalization. Genomics (2013) 1.03
Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int (2011) 1.03
Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis (2007) 1.02
Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival. Am J Hematol (2010) 1.01
The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila) (2010) 1.01
Methyl bromide exposure and cancer risk in the Agricultural Health Study. Cancer Causes Control (2012) 1.01
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood (2009) 1.01
Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method. Bioinformatics (2009) 1.01
Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer (2014) 0.99
Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer. Cancer Lett (2011) 0.99
Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol (2007) 0.99
Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev (2006) 0.99
Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol (2004) 0.98
Epidural abscess as a delayed complication of spinal instrumentation in scoliosis surgery: a case of progressive neurologic dysfunction with complete recovery. Spine (Phila Pa 1976) (2008) 0.98
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol (2011) 0.98
Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol (2008) 0.98
Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood (2010) 0.97
Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res (2009) 0.97
Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Common variants in genes that mediate immunity and risk of multiple myeloma. Int J Cancer (2007) 0.96
Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics (2007) 0.96
Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2009) 0.96
Anthropometric predictors of visceral adiposity in normal-weight and obese adolescents. Pediatr Diabetes (2013) 0.96
PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med (2007) 0.95
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol (2012) 0.95
Dietary (n-3)/(n-6) fatty acid ratio: possible relationship to premenopausal but not postmenopausal breast cancer risk in U.S. women. J Nutr (2003) 0.95
Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leuk Res (2009) 0.94